|
 |
|
Top 10 Leading Diagnostics Companies
This report is designed to provide the in vitro diagnostics industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The study's major objectives include: - To establish a comprehensive, factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world's leading in vitro diagnostics companies....
|
 |
|
$14800.00 |
| |
|
|
|
Leading Diagnostics Companies Financial Analyses
Each company�s analysis provides: |
|
|
$3500.00 |
| |
|
|
|
The 2019 Leading Diagnostics Companies Product Portfolio Analyses
For each company, the analyses present:- Review of major product lines.
- Specifications, features, advantages, weaknesses, introduction dates and prices of current analyzers, reagent systems and ancillary products....
|
|
|
$2850.00 |
| |
|
|
|
Global Diagnostics Market Dynamics and Trends
The report provides an approximately 55-page worldwide strategic overview of the in vitro diagnostics market, including: - Five-year reagent and instrument sales forecasts for major testing locations (hospitals, commercial/private laboratories, physician offices/group practices, blood center, personal testing and others and major laboratory disciplines (blood typing/grouping, chemist/immunoassay, coagulation, hematology/flow cytometry, histology/cytology, microbiology/serology, urinalysis and others).
- Five-year worldwide sales projections for the most dynamic market segments, such as molecular diagnostics, infectious diseases, tumor markers, and personal testing are developed....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Strategic Directions
For each company, the report provides insightful strategic assessments, including:- Business, new product development, and marketing strategies.
- Anticipated acquisitions, joint ventures, and divestitures....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Marketing Tactics
For each company, the analysis presents: |
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Collaborations
For each company, the report analyzes:- Major joint venture, distribution, O.E....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Company Business Organizations and Senior Management
For each company, the report provides:- History of the diagnostics business evolution important to the understanding of the company�s culture management mentality and strategies.
- Most recent significant acquisitions, divestitures and organizational changes....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies R&D Expenditures and Major Programs
For each company, the report provides:- R&D budget, research facilities, and staff.
- New technologies, systems, and applications in development, including their specifications and anticipated introduction dates....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Technological Know-How
For each company, the report analyzes:- Internally developed and acquired in vitro diagnostics.
- Know-how in biotechnology, engineering, electronics and other related fields....
|
|
|
$2450.00 |
| |
|
|
|
Leading Diagnostics Companies Facilities and Employees
For each company, the analyses present:- Location and size of administrative, manufacturing, and R&D facilities in the U.S....
|
|
|
$2450.00 |
| |
|
|
|
Abbott: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Abbott, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 114 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Bayer Diabetes: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Bayer Diabetes, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 108 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Beckman Coulter: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Beckman Coulter, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 97 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Becton Dickinson: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Becton Dickinson, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 95 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
bioMerieux: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostic Imaging Market
A strategic assessment of bioMerieux, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 41 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
Bio-Rad: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of Bio-Rad, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 30 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
J & J: Performance, Capabilities, Goals and Strategies in the Worldwide Diagnostics Market
A strategic assessment of J & J, one of the world's leading diagnostics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals, and strategies in the global diagnostics market.Contains 95 pages and 5 tables
|
|
|
$2450.00 |
| |
|
|
|
|